<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Sanders | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/healthloan3/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/healthloan3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Sanders.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">22d0bf85105c906723125828a223843a</guid>
				<title>Sanders posted an update: Suppression of antitumor immune responses is one of the main [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42996/</link>
				<pubDate>Sun, 09 Feb 2025 12:23:02 -0800</pubDate>

									<content:encoded><![CDATA[<p>Suppression of antitumor immune responses is one of the main mechanisms by which tumor cells escape from destruction by the immune system. Myeloid-derived suppressor cells (MDSCs) represent the main immunosuppressive cells present in the tumor microenvironment (TME) that sustain cancer progression. MDSCs are a heterogeneous group of immature&hellip;<span class="activity-read-more" id="activity-read-more-42996"><a href="http://www.nationalboardinstitute.com/activity/p/42996/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8a525731042ad33b282783b1fde682e8</guid>
				<title>Sanders posted an update: Ischemic stroke leads to neuronal cell death and induces a [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40546/</link>
				<pubDate>Thu, 06 Feb 2025 17:38:35 -0800</pubDate>

									<content:encoded><![CDATA[<p>Ischemic stroke leads to neuronal cell death and induces a cascade of inflammatory signals that results in secondary brain damage. Although constant efforts to develop therapeutic strategies and to reveal the molecular mechanism resulting in the physiopathology of this disease, much still remains unclear. Membrane-bound Toll-like receptors (TLRs)&hellip;<span class="activity-read-more" id="activity-read-more-40546"><a href="http://www.nationalboardinstitute.com/activity/p/40546/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b64efa25206562e29603aea6a88530c9</guid>
				<title>Sanders posted an update: PICU clinicians should expect spiritual statements in care [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37795/</link>
				<pubDate>Mon, 03 Feb 2025 12:19:45 -0800</pubDate>

									<content:encoded><![CDATA[<p>PICU clinicians should expect spiritual statements in care conferences and be prepared to respond.</p>
<p>In this single-centre PICU, spiritual statements were present 46% of the time during high stakes decision-making conferences, but there was little evidence of spiritual care best practices, such as offering chaplain support and performing&hellip;<span class="activity-read-more" id="activity-read-more-37795"><a href="http://www.nationalboardinstitute.com/activity/p/37795/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">50a8b7278e8ce3ef4c83cba845024e33</guid>
				<title>Sanders posted an update: In CL patients with molecular evidence of Leishmania [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34250/</link>
				<pubDate>Thu, 30 Jan 2025 12:16:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>In CL patients with molecular evidence of Leishmania persistence in the NM, genes characteristic of an anti-inflammatory and tissue repair responses (IL4R, IL5RA, POSTN and SATB1) were over-expressed relative to NM samples from CL patients in which Leishmania was not detected. Here, we report the first immunological description of subclinically&hellip;<span class="activity-read-more" id="activity-read-more-34250"><a href="http://www.nationalboardinstitute.com/activity/p/34250/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f751e093aa6532baee8aacd73080c548</guid>
				<title>Sanders posted an update: Most referrals (85%) were for IHD; 15% were for HFrEF. Early [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31238/</link>
				<pubDate>Tue, 28 Jan 2025 16:33:48 -0800</pubDate>

									<content:encoded><![CDATA[<p>Most referrals (85%) were for IHD; 15% were for HFrEF. Early termination occurred in 206 patients (18%) and was more common in HFrEF (26%) than in IHD (17%) (P less then .01). After multivariable adjustment, patients with HFrEF remained at higher risk of early termination than patients with IHD (unadjusted OR = 1.73, 95% CI, 1.17-2.54; adjusted OR&hellip;<span class="activity-read-more" id="activity-read-more-31238"><a href="http://www.nationalboardinstitute.com/activity/p/31238/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">46d6a98cc49124393e985aa0b8ed147d</guid>
				<title>Sanders became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/31221/</link>
				<pubDate>Tue, 28 Jan 2025 16:31:01 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>